Mergers and Acquisitions
Company discusses GenSci merger and announces plans to streamline
Published in Blood Weekly, October 2nd, 2003
In addition, IsoTis announced further steps to streamline its operations.
IsoTis' management, in its continued effort to rationalize its operations and to fully focus on orthobiologics, intends to discontinue or spin-off all its cell biology programs. This would involve putting on hold the development of VivesCart, a long-term tissue engineered cartilage development program; the transfer of people...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-10-02)
More Articles from Blood Weekly
- Stem-Cell Transplantation
Intensive SCT conditioning regimen effective for high-risk leukemia patients - Stem-Cell Transplantation
Oral tolerance induction may reduce GVHD risk in stem-cell graft recipients - Blood Substitute
Novel LC-based assay detects Hemopure doping in athletes - Chronic Myeloid Leukemia
Stem cell transplantation benefits confirmed for pediatric CML patients - Stem-Cell Transplantation
Fludarabine-melphalan regimen increases post-SCT T-cell engraftment, GVHD risk - Stem-Cell Transplantation
Monthly chimerism analysis can predict stem-cell graft failure - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
